Treatment of Ascites
OwnerPaolo Angeli, Penelope Markham +1inventors
InventorsPaolo Angeli, Penelope Markham, Jonathan Adams
Life of this patent
Estimating the term…
Abstract
A method for treating ascites patients by administering the peptide drug terlipressin by continuous infusion. The patients include those whose ascites condition has not progressed to hepatorenal syndrome (HRS). Administration may be accomplished with a continuous infusion pump.
Claims11
-20. (canceled)
A method for treating ascites in a non-hepatorenal syndrome (HRS) patient diagnosed with ascites due to liver cirrhosis, the method consisting of administering a continuous infusion of terlipressin or salt thereof to the patient at a continuous infusion dose of about 2.0 mg to about 12.0 mg of terlipressin per day for a duration of about one day to about twelve months, wherein the patient is not hospitalized and the patient is not administered diuretics during the duration, and wherein the ascites in the patient is reduced.
Dependencies are inferred from the claim text.